AzTrials
AzTrials

Heart FailureNCT07068308

Effects of a Wed-based FRAIL-SM Program Among Patients With Heart Failure

A study testing web-based FRAIL-SM program in people with Heart Failure, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to examine the effects of web-based FRAIL-SM (Family involvement, self-Regulation skills training, Autonomy, Information sharing and Linkage, Self-Management) on frailty, self-management behaviors and quality of life in patients with heart failure and their families' heart failure knowledge… Read more about this study

Who is it for?
Ages 20 years and older
Conditions the study is for
Heart Failure
What is being tested?
web-based FRAIL-SM program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
328 participants
Where
1 siteTaiwan
Study dates
1 Jan 2026to 31 Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged above 20.
  • Diagnosed with heart failure or LVEF<40%.
  • Clear consciousness, can communicate with Chinese and Taiwanese.
  • Consent to join in this study and have family partner.
  • Access to computer or smartphone
  • Meet one of the Study of Osteoporotic Fractures of frailty
Show all 10Show fewer
  • Aged above 20.
  • Clear consciousness, can communicate with Chinese and Taiwanese.
  • Consent to join in this study and willing to accompany with patients.
  • Access to computer or smartphone

Who cannot join

  • Bed-ridden or unable to perform activities of daily living independently.
  • Diagnosed with cognitive, psychiatric disease, or major depression.
  • Acute disease condition e.g. infection or thrombosis.
  • Contraindications of performing exercise such as uncontrolled hypertension, uncontrolled arrhythmia.
  • severe neurodegenerative or muscular diseases, e.g. parkinson's disease, arthritis.
  • Family criteria:
Show all 9Show fewer
  • Bed-ridden or unable to perform activities of daily living independently.
  • Diagnosed with cognitive, psychiatric disease, or major depression.
  • Have employment relationship with patients

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ai-Fu Chiou, PhD contact

886-2-28267354

afchiou@nycu.edu.tw

Taiwan1 site
  • National Yang Ming Chiao Tung University

    Taipei, 112

    Ai-Fu Chiou Professor, PhD, 886-2-28267354, afchiou@nycu.edu.tw

Other trials in Taiwan

About this study

Official title: Development and Effectiveness of a Wed-based FRAIL-SM Program Among Patients With Heart Failure

This study aims to examine the effects of web-based FRAIL-SM (Family involvement, self-Regulation skills training, Autonomy, Information sharing and Linkage, Self-Management) on frailty, self-management behaviors and quality of life in patients with heart failure and their families' heart failure knowledge, confidence, strain, and quality of life. Patients are recruited with a convenience sampling from two medical centers in Taiwan. The web-based FRAIL-SM includes Family involvement, self-Regulation, Autonomy support, Information sharing and Linkage.

Read the detailed description

A randomized controlled trial is conducted. Subjects are selected using a convenience sampling and are randomly assigned to the intervention or control group by stratified randomization according to participation of post-acute care. Patients in the intervention group will receive an 8-week web-based FRAIL-SM program. Data is collected by researchers using a structural questionnaire including frailty, heart failure knowledge, self-care of heart failure, and quality of life and physical indicators such as levels of B-type natriuretic peptide, hemoglobin, hematocrit, albumin at baseline, 4 weeks, 8 weeks, 12 weeks and 24 weeks after enrollment.

Conditions
Heart Failure
Being tested
web-based FRAIL-SM program
Keywords
frailty, heart failure, self-management, web-based frailty self-management program, knowledge, family caregiver, quality of life
Medical subject headings
Heart Failure, Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • web-based FRAIL-SM programBehavioural

    The 8-week web-based FRAIL-SM includes family involvement, self-regulation, autonomy support, information sharing and linkage.

Study groups in NCT07068308
Study groupRoleWhat they receive
wed-based FRAIL-SM programExperimentalPatients in the intervention group will receive an 8-week web-based FRAIL-SM program including family involvement, self-regulation, autonomy support, information sharing and linkage.
Receives: Behavioral: web-based FRAIL-SM program
control groupNo interventionPatients in this group will receive usual care.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in Frailty Assessment Scale for Heart Failure scores

    Changes from baseline Frailty Assessment Scale for Heart Failure scores to at 4 weeks, 8 weeks, 12 weeks and 24 weeks after enrollment. The Frailty Assessment Scale for Heart Failure contains 15 items, each item use Likert scale four point scoring (0-3), the total scores ranged from 0 to 45, the higher scores indicate higher levels of frailty.

    Measured: baseline, 4 weeks, 8 weeks, 12 weeks, 24 weeks

  2. Changes in Dutch Heart Failure Knowledge Scale scores

    Changes from baseline Dutch Heart Failure Knowledge Scale scores to at 4 weeks, 8 weeks, 12 weeks and 24 weeks after enrollment. The Dutch Heart Failure Knowledge Scale contains 15 items. The total scores ranged from 0 to 15, the higher scores indicate higher levels of knowledge.

    Measured: baseline, 4 weeks, 8 weeks, 12 weeks, 24 weeks

  3. Changes in Self-Care of Heart Failure Index scores

    Changes from baseline Self-Care of Heart Failure Index scores to at 4 weeks, 8 weeks, 12 weeks and 24 weeks after enrollment. The Self-Care of Heart Failure Index contains 22 items, three subscales: self-care maintenance, self-care management, self-care confidence. Each subscale scores ranged from 0 to 100, the higher scores indicate higher levels of self-care maintenance, self-care management, self-care confidence.

    Measured: baseline, 4 weeks, 8 weeks, 12 weeks, 24 weeks

  4. Changes in Minnesota Living with Heart Failure questionnaire scores

    Changes from baseline Minnesota Living with Heart Failure questionnaire scores to at 4 weeks, 8 weeks, 12 weeks and 24 weeks after enrollment. The Minnesota Living with Heart Failure questionnaire contains 21 items, each item scores ranged from 0 to 5. The total socre ranged from 0 to 105, the higher scores indicate higher levels of impact on quality of life.

    Measured: baseline, 4 weeks, 8 weeks, 12 weeks, 24 weeks

Secondary outcomes (2)
  1. Changes in World Health Organization Quality of Life - BREF (WHOQOL-BREF) scale scores

    Changes from baseline World Health Organization Quality of Life - BREF (WHOQOL-BREF) Scale scores to at 4 weeks, 8 weeks, 12 weeks and 24 weeks after enrollment. The WHOQOL-BREF scale contains 28 items, four dimensions. Each dimension scores ranged from 4 to 20, the higher scores indicate higher levels of quality of life.

    Measured: baseline, 4 weeks, 8 weeks, 12 weeks, 24 weeks

  2. Changes in Caregiver Strain Index scores

    Changes from baseline Caregiver Strain Index scores to at 4 weeks, 8 weeks, 12 weeks and 24 weeks after enrollment. The Scale contains 13 items, the total scores ranged from 0 to 13, the higher scores indicate higher levels of strain.

    Measured: baseline, 4 weeks, 8 weeks, 12 weeks and 24 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jul 2025
  2. Study start1 Jan 2026 (estimated)
  3. Primary completion31 May 2027 (estimated)
  4. Study completion31 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
328 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07068308
Sponsor's protocol ID
NYCU113069AE
Status last verified
Nov 2024
First submitted
6 Jul 2025
Last updated
25 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing web-based FRAIL-SM program in people with Heart Failure, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 25 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ai-Fu Chiou, PhD (886-2-28267354, afchiou@nycu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in Frailty Assessment Scale for Heart Failure scores (time frame: baseline, 4 weeks, 8 weeks, 12 weeks, 24 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in